Earnings ·
Sotera Health reports Q3 net income of $58M or $0.20 per diluted share
SHCSotera Health Co
Sotera Health Company reported third-quarter 2026 financial results with net revenues increasing 4.4% to $324.9 million and net income of $58 million, or $0.20 per diluted share. Adjusted EBITDA rose 3.9% to $170.7 million, while Adjusted EPS increased 12% to $0.29. The company reaffirmed its full-year 2026 outlook for net revenues growth of 5.25%-6.75% and Adjusted EBITDA growth of 5.75%-7.25%. Sotera Health operates as a leading global provider of mission-critical end-to-end sterilization solutions, lab testing, and advisory services for the healthcare industry.